⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
Shareholders of Aardvark Therapeutics, Inc. (AARD): Protect Your Rights Before October 13, 2026 – Contact Levi & Korsinsky
accessnewswire.com
AARD
Shareholders of Aardvark Therapeutics, Inc. (AARD): Protect Your Rights Before October 13, 2026 – Contact Levi & Korsinsky
accessnewswire.com
AARD
Securities Lawsuit Alert: Aardvark Therapeutics, Inc. (AARD) Investors – Contact Levi & Korsinsky Before October 13, 2026
accessnewswire.com
AARD
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Aardvark Therapeutics, Inc. (AARD) Investors of October 13, 2026 Deadline
accessnewswire.com
AARD
Investor Alert: Deadline Approaching to Join Aardvark Therapeutics, Inc. (AARD) Class Action – Contact Levi & Korsinsky
accessnewswire.com
AARD
Lost Money on Aardvark Therapeutics, Inc. (AARD)? Join Class Action Before October 13, 2026 – Contact Levi & Korsinsky
accessnewswire.com
AARD
Securities Lawsuit Alert: Aardvark Therapeutics, Inc. (AARD) – Contact Levi & Korsinsky Before October 13, 2026
accessnewswire.com
AARD
Pomerantz LLP Moves Forward with Class Action Litigation Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD
accessnewswire.com
AARD
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AARD
globenewswire.com
AARD